Structural determinants of the C-terminal helix-kink-helix motif essential for protein stability and survival promoting activity of DJ-1

J Biol Chem. 2007 May 4;282(18):13680-91. doi: 10.1074/jbc.M609821200. Epub 2007 Mar 1.

Abstract

Mutations in the PARK7 gene encoding DJ-1 cause autosomal recessive Parkinson disease. The most deleterious point mutation is the L166P substitution, which resides in a structure motif comprising two alpha-helices (G and H) separated by a kink. Here we subjected the C-terminal helix-kink-helix motif to systematic site-directed mutagenesis, introducing helix-incompatible proline residues as well as conservative substitutions into the helical interface. Furthermore, we generated deletion mutants lacking the H-helix, the kink, and the entire C terminus. When transfected into neural and nonneural cell lines, steady-state levels of G-helix breaking and kink deletion mutants were dramatically lower than wild-type DJ-1. The effects of H-helix breakers were comparably smaller, and the non-helix breaking mutants only slightly destabilized DJ-1. The decreased steady-state levels were due to accelerated protein degradation involving in part the proteasome. G-helix breaking DJ-1 mutations abolished dimer formation. These structural perturbations had functional consequences on the cytoprotective activities of DJ-1. The destabilizing mutations conferred reduced cytoprotection against H(2)O(2) in transiently retransfected DJ-1 knock-out mouse embryonic fibroblasts. The loss of survival promoting activity of the DJ-1 mutants with destabilizing C-terminal mutations correlated with impaired anti-apoptotic signaling. We found that wild-type, but not mutant DJ-1 facilitated the Akt pathway and simultaneously blocked the apoptosis signal-regulating kinase 1, with which DJ-1 interacted in a redox-dependent manner. Thus, the G-helix and kink are critical determinants of the C-terminal helix-kink-helix motif, which is absolutely required for stability and the regulation of survival-promoting redox signaling of the Parkinson disease-associated protein DJ-1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Motifs / genetics
  • Animals
  • Apoptosis* / drug effects
  • Apoptosis* / genetics
  • Cell Survival / drug effects
  • Cell Survival / genetics
  • Cytoprotection* / drug effects
  • Cytoprotection* / genetics
  • Embryo, Mammalian / metabolism
  • Fibroblasts / metabolism
  • Humans
  • Hydrogen Peroxide / pharmacology
  • Intracellular Signaling Peptides and Proteins / genetics
  • MAP Kinase Kinase Kinase 5 / genetics
  • MAP Kinase Kinase Kinase 5 / metabolism
  • Mice
  • Mice, Knockout
  • Mutagenesis, Site-Directed
  • Mutation, Missense*
  • Oncogene Proteins / biosynthesis*
  • Oncogene Proteins / genetics
  • Oxidants / pharmacology
  • PC12 Cells
  • Parkinson Disease / genetics
  • Parkinson Disease / metabolism
  • Peroxiredoxins
  • Protein Deglycase DJ-1
  • Protein Folding*
  • Protein Processing, Post-Translational / drug effects
  • Protein Processing, Post-Translational / genetics
  • Protein Structure, Tertiary / genetics
  • Proto-Oncogene Proteins c-akt / genetics
  • Proto-Oncogene Proteins c-akt / metabolism
  • Rats
  • Signal Transduction* / drug effects
  • Signal Transduction* / genetics
  • Structure-Activity Relationship

Substances

  • Intracellular Signaling Peptides and Proteins
  • Oncogene Proteins
  • Oxidants
  • Hydrogen Peroxide
  • Peroxiredoxins
  • Proto-Oncogene Proteins c-akt
  • MAP Kinase Kinase Kinase 5
  • PARK7 protein, human
  • PARK7 protein, mouse
  • Protein Deglycase DJ-1